Ubs Group Ag Syros Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
BUY
$0.69 - $1.21 $752 - $1,318
1,090 Added 218.0%
1,590 $1,000
Q1 2022

May 16, 2022
SELL
$1.02 - $3.8 $26,682 - $99,404
-26,159 Reduced 98.12%
500 $1,000
Q4 2021

Feb 14, 2022
BUY
$3.26 - $4.66 $71,260 - $101,862
21,859 Added 455.4%
26,659 $87,000
Q3 2021

Nov 15, 2021
SELL
$4.08 - $5.66 $35,157 - $48,772
-8,617 Reduced 64.22%
4,800 $21,000
Q2 2021

Aug 13, 2021
BUY
$5.01 - $7.48 $50,370 - $75,203
10,054 Added 298.96%
13,417 $73,000
Q1 2021

May 12, 2021
SELL
$7.19 - $14.95 $68,571 - $142,578
-9,537 Reduced 73.93%
3,363 $25,000
Q4 2020

Feb 11, 2021
BUY
$6.66 - $14.66 $44,622 - $98,222
6,700 Added 108.06%
12,900 $140,000
Q3 2020

Nov 12, 2020
SELL
$8.69 - $14.47 $59,170 - $98,526
-6,809 Reduced 52.34%
6,200 $55,000
Q2 2020

Jul 31, 2020
SELL
$5.21 - $11.03 $19,448 - $41,174
-3,733 Reduced 22.3%
13,009 $139,000
Q1 2020

May 01, 2020
SELL
$4.46 - $9.2 $123,747 - $255,263
-27,746 Reduced 62.37%
16,742 $99,000
Q4 2019

Feb 14, 2020
BUY
$4.52 - $10.1 $98,739 - $220,634
21,845 Added 96.48%
44,488 $307,000
Q3 2019

Nov 14, 2019
BUY
$7.14 - $11.65 $120,273 - $196,244
16,845 Added 290.53%
22,643 $235,000
Q2 2019

Aug 14, 2019
BUY
$5.5 - $9.75 $4,350 - $7,712
791 Added 15.8%
5,798 $53,000
Q1 2019

May 14, 2019
BUY
$5.51 - $9.59 $13,482 - $23,466
2,447 Added 95.59%
5,007 $46,000
Q4 2018

Feb 14, 2019
SELL
$5.55 - $11.34 $52,602 - $107,480
-9,478 Reduced 78.73%
2,560 $14,000
Q3 2018

Nov 14, 2018
BUY
$9.74 - $12.92 $51,466 - $68,269
5,284 Added 78.24%
12,038 $144,000
Q2 2018

Aug 14, 2018
BUY
$10.16 - $13.65 $41,757 - $56,101
4,110 Added 155.45%
6,754 $69,000
Q1 2018

May 15, 2018
SELL
$9.47 - $12.98 $8,238 - $11,292
-870 Reduced 24.76%
2,644 $34,000
Q4 2017

Feb 14, 2018
BUY
$8.45 - $17.48 $20,423 - $42,249
2,417 Added 220.33%
3,514 $35,000
Q3 2017

Nov 14, 2017
BUY
$13.52 - $23.75 $3,920 - $6,887
290 Added 35.94%
1,097 $16,000
Q2 2017

Aug 14, 2017
BUY
N/A
28 Added 3.59%
807 $13,000
Q1 2017

Nov 14, 2017
BUY
N/A
779
779 $12,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $5.87M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email